Blood derivatives manufacturing · California

Kite Pharma, Inc.

El Segundo, CA · ~630 workers · 4 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
1.6
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Kite Pharma, Inc. runs at 49% of its industry's injury rate - far safer than the typical Blood derivatives manufacturing workplace, earning a grade A.

Kite Pharma, Inc.: 1.6 TCR = 49% of Blood derivatives manufacturing BLS 3.3 · 4y Form 300A (see methodology below)

Kite Pharma, Inc. safety composite

Kite Pharma, Inc. scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on total case rate (tcr) (safer than 35%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

41/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
D 1.62 per 100 workers

Safer than 35% of industry peers

DART rate
D 0.65 per 100 workers

Safer than 41% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Kite Pharma, Inc. held a steady TCR band

Kite Pharma, Inc.'s TCR held near 0.0 from 0.8 in 2017 to 0.8 in 2024. Peak filing year was 2022 at 3.6 TCR. In 2024, DART was 0.4× this establishment's average TCR (severity share of cases).

2017=0.8 · 2022=3.6 · 2023=1.3 · 2024=0.8

OSHA ITA Form 300A scorecard

Establishment book 325414 · El Segundo, CA AT/BELOW-IND · MID

Grade A · TCR 1.6 · 49% of ind

  • DART 0.7 DART
  • RANK #14/29
  • PHOTO SAFC Biosciences
  • BOOK 4y book
  • INJ 18 inj
  • SIZE ~630 FTE

Nearest TCR peer: SAFC Biosciences (0.0 TCR gap)

Read with this employer → · Industry book → · California employers → · Look up another →

Kite Pharma, Inc. in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Kite Pharma, Inc. averages 1.6 TCR (49% of the Blood derivatives manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Kite Pharma, Inc. TCR series: 2017=0.8 · 2022=3.6 · 2023=1.3 · 2024=0.8 · BLS 3.3

Where Kite Pharma, Inc. falls in its industry

234 Blood derivatives manufacturin establishments

Safer than 35% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #14 safest of 29 Blood derivatives manufacturin employers in California.

Kite Pharma, Inc. (630 employees, TCR 1.6) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate Kite Pharma, Inc.
Kite Pharma, Inc. (630 employees, TCR 1.6) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Kite Pharma, Inc. has more employees than the Blood derivatives manufacturing median and a higher injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.8 0.7 4 2 0
2023 1.3 1.1 7 4 0
2022 3.6 3.2 6 21 0
2017 0.8 0.8 1 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · CA · El Segundo

234 Blood derivatives manufacturing employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 121 employers in El Segundo, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR SAFC Biosciences 1.6 TCR
NAICS-TCR Shire Georgia 1.6 TCR
NAICS-TCR Aldevron, LLC 1.6 TCR
NAICS-TCR Pilot Plant 1.6 TCR
STATE-SIZE Whole Company - Power Plus! 630 FTE
STATE-SIZE CA - Adidas (Bloomington) 630 FTE
STATE-SIZE Proctor and Gamble WCMC 630 FTE
STATE-SIZE City of Bakersfield Police Department 630 FTE
CITY-NEAR Raytheon_El Segundo_CA 5,443 FTE
CITY-NEAR CA011 3,282 FTE
CITY-NEAR NGAS-A113 2,490 FTE
CITY-NEAR Northrup Grumman Systems Corporation 1,934 FTE
NAT-TCR Carrier Commercial Services (Phoenix) 1.6 TCR
NAT-TCR Carrier Commercial Services (Centennial) 1.6 TCR
NAT-TCR DSS025 1.6 TCR
NAT-TCR Belt Construction Inc. 1.6 TCR
NAT-SIZE PECO Foods West Point 630 FTE
NAT-SIZE Master Klean Janitorial, INC 630 FTE
NAT-SIZE Corteva Agriscience Puerto Rico, Inc. 630 FTE
NAT-SIZE 1223 Swn1000 630 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022, 2017. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.